Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

StandardStandard

Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. / Hughes, D.; Verhof, T.I.; Redekop, W.K. et al.
Yn: Pharmacogenomics, Cyfrol 13, Rhif 12, 01.09.2012, t. 1405-1417.

Allbwn ymchwil: Cyfraniad at gyfnodolynErthygladolygiad gan gymheiriaid

HarvardHarvard

Hughes, D, Verhof, TI, Redekop, WK, van Schie, RM, Bayat, S, Daly, AK, Geitona, M, Haschke-Becher, E, Hughes, DA, Kamali, F, Levin, LA, Manolopoulos, VG, Pirmohamed, M, Siebert, U, Stingl, JC, Wadelius, M, de Boer, A & Maitland-van der Zee, AH 2012, 'Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs', Pharmacogenomics, cyfrol. 13, rhif 12, tt. 1405-1417.

APA

Hughes, D., Verhof, T. I., Redekop, W. K., van Schie, R. M., Bayat, S., Daly, A. K., Geitona, M., Haschke-Becher, E., Hughes, D. A., Kamali, F., Levin, L. A., Manolopoulos, V. G., Pirmohamed, M., Siebert, U., Stingl, J. C., Wadelius, M., de Boer, A., & Maitland-van der Zee, A. H. (2012). Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics, 13(12), 1405-1417.

CBE

Hughes D, Verhof TI, Redekop WK, van Schie RM, Bayat S, Daly AK, Geitona M, Haschke-Becher E, Hughes DA, Kamali F, et al. 2012. Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics. 13(12):1405-1417.

MLA

VancouverVancouver

Hughes D, Verhof TI, Redekop WK, van Schie RM, Bayat S, Daly AK et al. Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Pharmacogenomics. 2012 Medi 1;13(12):1405-1417.

Author

Hughes, D. ; Verhof, T.I. ; Redekop, W.K. et al. / Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. Yn: Pharmacogenomics. 2012 ; Cyfrol 13, Rhif 12. tt. 1405-1417.

RIS

TY - JOUR

T1 - Cost–effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs

AU - Hughes, D.

AU - Verhof, T.I.

AU - Redekop, W.K.

AU - van Schie, R.M.

AU - Bayat, S.

AU - Daly, A.K.

AU - Geitona, M.

AU - Haschke-Becher, E.

AU - Hughes, D.A.

AU - Kamali, F.

AU - Levin, L.A.

AU - Manolopoulos, V.G.

AU - Pirmohamed, M.

AU - Siebert, U.

AU - Stingl, J.C.

AU - Wadelius, M.

AU - de Boer, A.

AU - Maitland-van der Zee, A.H.

PY - 2012/9/1

Y1 - 2012/9/1

M3 - Article

VL - 13

SP - 1405

EP - 1417

JO - Pharmacogenomics

JF - Pharmacogenomics

SN - 1744-8042

IS - 12

ER -